Regulator asks states to enforce strict compliance with Schedule M drugs

IN a bid to enforce Good Manufacturing Practices (GMP) at drug manufacturing companies, India's drug regulator has asked all states and union territories (UTs) to confirm strict compliance with the revised Schedule M norms.

- KAVITA BAJELI-DATT @New Delhi

In a notice to all state and UT drug controllers, the Drugs Controller General of India (DCGI), Dr Rajeev Singh Raghuvanshi, said, "Immediate inspection and action shall be initiated right now for those units that have not applied for the extension, as the revised Schedule M is already applicable for such units."